BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32882523)

  • 21. Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-alpha be better?
    Bonvalot S; Laplanche A; Lejeune F; Stoeckle E; Le Péchoux C; Vanel D; Terrier P; Lumbroso J; Ricard M; Antoni G; Cavalcanti A; Robert C; Lassau N; Blay JY; Le Cesne A
    Ann Oncol; 2005 Jul; 16(7):1061-8. PubMed ID: 15930042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolated limb perfusion for unresectable melanoma of the extremities.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
    Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB
    Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life after hyperthermic isolated limb perfusion for locally advanced extremity soft tissue sarcoma.
    Thijssens KM; Hoekstra-Weebers JE; van Ginkel RJ; Hoekstra HJ
    Ann Surg Oncol; 2006 Jun; 13(6):864-71. PubMed ID: 16614886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolated limb perfusion: what is the evidence for its use?
    Noorda EM; Vrouenraets BC; Nieweg OE; Van Coevorden F; Kroon BB
    Ann Surg Oncol; 2004 Sep; 11(9):837-45. PubMed ID: 15313738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolated limb perfusion in the management of locally advanced extremity soft tissue sarcoma.
    Eggermont AM
    Surg Oncol Clin N Am; 2003 Apr; 12(2):469-83. PubMed ID: 12916464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO).
    Di Filippo F; Giacomini P; Rossi CR; Santinami M; Garinei R; Anzà M; Deraco M; Botti C; Perri P; Cavaliere F; Di Angelo P; Sofra C; Sperduti I; Pasqualoni R; Di Filippo S; Corrias F; Armenti A; Ferraresi V
    In Vivo; 2009; 23(2):363-7. PubMed ID: 19414428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: three time periods at risk for amputation.
    van Ginkel RJ; Thijssens KM; Pras E; van der Graaf WT; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2007 Apr; 14(4):1499-506. PubMed ID: 17253101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolated limb perfusion and external beam radiotherapy for soft tissue sarcomas of the extremity: long-term effects on normal tissue according to the LENT-SOMA scoring system.
    Hoven-Gondrie ML; Thijssens KM; Geertzen JH; Pras E; van Ginkel RJ; Hoekstra HJ
    Ann Surg Oncol; 2008 May; 15(5):1502-10. PubMed ID: 18330652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved survival for soft tissue sarcoma of the extremities by regional hyperthermic perfusion, local excision and radiation therapy.
    Lehti PM; Moseley HS; Janoff K; Stevens K; Fletcher WS
    Surg Gynecol Obstet; 1986 Feb; 162(2):149-52. PubMed ID: 3945892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in advanced soft-tissue sarcomas: histopathological considerations.
    Issakov J; Merimsky O; Gutman M; Kollender Y; Lev-Chelouche D; Abu-Abid S; Lifschitz-Mercer B; Inbar M; Klausner JM; Meller I
    Ann Surg Oncol; 2000 Mar; 7(2):155-9. PubMed ID: 10761796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
    Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
    Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperthermic isolated limb perfusion with tumour necrosis factor and melphalan as treatment of locally advanced or recurrent soft tissue sarcomas of the extremities.
    Schraffordt Koops H; Eggermont AM; Liènard D; Kroon BB; Hoekstra HJ; van Geel AN; Nieweg OE; Lejeune FJ
    Radiother Oncol; 1998 Jul; 48(1):1-4. PubMed ID: 9756165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MFH revisited: outcome after surgical treatment of undifferentiated pleomorphic or not otherwise specified (NOS) sarcomas of the extremities -- an analysis of 140 patients.
    Lehnhardt M; Daigeler A; Homann HH; Schwaiberger V; Goertz O; Kuhnen C; Steinau HU
    Langenbecks Arch Surg; 2009 Mar; 394(2):313-20. PubMed ID: 18584203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TNF-based isolated limb perfusion in unresectable extremity desmoid tumours.
    Grünhagen DJ; de Wilt JH; Verhoef C; van Geel AN; Eggermont AM
    Eur J Surg Oncol; 2005 Oct; 31(8):912-6. PubMed ID: 16098709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolated limb infusion for advanced soft tissue sarcoma of the extremity.
    Moncrieff MD; Kroon HM; Kam PC; Stalley PD; Scolyer RA; Thompson JF
    Ann Surg Oncol; 2008 Oct; 15(10):2749-56. PubMed ID: 18648882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional and oncological outcomes after limb-salvage surgery for primary sarcomas of the upper limb.
    Wright EH; Gwilym S; Gibbons CL; Critchley P; Giele HP
    J Plast Reconstr Aesthet Surg; 2008; 61(4):382-7. PubMed ID: 17889633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of multidrug resistance genes MVP, MDR1, and MRP1 determined sequentially before, during, and after hyperthermic isolated limb perfusion of soft tissue sarcoma and melanoma patients.
    Stein U; Jürchott K; Schläfke M; Hohenberger P
    J Clin Oncol; 2002 Aug; 20(15):3282-92. PubMed ID: 12149303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolated limb perfusion with cisplatin and doxorubicin for locally advanced soft tissue sarcoma of an extremity.
    Eroglu A; Kocaoglu H; Demirci S; Akgül H
    Eur J Surg Oncol; 2000 Apr; 26(3):213-21. PubMed ID: 10753532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
    Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
    J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.